Agreement between the FDA and the ANSM

Already inspected by the FDA in 2015, then reassessed this year, the ANSM (French Agency for the Safety of Medicines and Healthcare Products) has just been officially approved by the United States to inspect French pharmaceutical sites on behalf of the FDA. The new text definitively endorses the first agreement signed in 1998 and targets all pharmaceutical and biological products for human and veterinary use. The ANSM specifies that this step will allow the resources allocated to inspections within the European Union to be rationalized in order to roll out more resources in other regions of the world.